Convano Inc. (Headquarters: Shibuya-ku, Tokyo; President and CEO: Kaminoshimo Aya; Securities Code: 6574; hereinafter referred to as "the Company") hereby announces that it has completed the payment for a third-party allocation of new shares on July 2, 2026, and has made Accel Mark Inc. (Securities Code: 3624) a consolidated subsidiary, following the share acquisition (consolidation as a subsidiary) announced on May 29, 2026. This consolidation as a subsidiary is one of the key measures in the Company's mid-term management plan and aims to further expand the healthcare business and enhance corporate value. ■Overview of this Matter The Company subscribed to a third-party allocation of new shares conducted by Accel Mark Inc., acquiring 45,000,000 common shares (450,000 voting rights). As a result, the Company's voting rights ownership ratio became 68.91%, and Accel Mark Inc. became a consolidated subsidiary of the Company as of July 2, 2026. Acquisition Summary Acquisition Method: Subscription to a third-party allocation of new shares Number of Shares Acquired: 45,000,000 shares Issue Price: 20 yen per share Share Acquisition Cost: 900 million yen Advisory Fees, etc.: Approximately 2 million yen Total Acquisition Amount: Approximately 902 million yen Voting Rights Ownership Ratio: 68.91% (rounded to the third decimal place) Effective Date: July 2, 2026 ■Future Outlook Through collaboration with Accel Mark Inc., the Company will further strengthen its business foundation in the healthcare domain. Moving forward, by leveraging the management resources and know-how held by both companies, we will work to expand healthcare-related businesses, create new businesses, and improve corporate value, while steadily promoting the growth strategies outlined in our mid-term management plan. Furthermore, by maximizing the synergies of the entire group, we aim to create new value and achieve sustainable growth. The Company will continue to strive for business domain expansion and enh